Business
Exercise of Warrants
Exercise of Warrants.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n RNS Number : 7137Z Allergy Therapeutics PLC 25 September 2009 \n \nFriday 25 September 2009 \n \n\n\nAllergy Therapeutics plc\n(\"Allergy Therapeutics\" or \"the Company\")\n\nExercise of Warrants \n\n\nAllergy Therapeutics (AIM: AGY) announces that on 24 September 2009, Azure Ventures Limited partially exercised the warrant to subscribe for ordinary shares in the Company issued to it on 1 July 2009. The exercise was in respect of 16,273,393 new ordinary shares (the \"Ordinary Shares\") at an exercise price of 12.29 pence per share for a total consideration of GBP2.0M.\n \nApplication has been made for the admission to trading on AIM (\"Admission\") of 16,273,393 Ordinary Shares at nominal value with Admission expected to take place on 1 October 2009, this now completes Azure's warrant rights. \n \nAzure Ventures Limited will be interested in 132,940,059 Ordinary Shares, representing 45.41 per cent. of the Company's total voting rights after Admission. \n \nAfter Admission, the Company's issued share capital will consist of 292,771,944 Ordinary Shares. \n \n \nFor further information\n\n\n\n\n\nAllergy Therapeutics\n\n\n+44 (0) 1903 845 820\n\n\n\n\nIan Postlethwaite, Finance Director\n\n\n\n\n\n\n\nwww.allergytherapeutics.com\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNomura Code Securities\n\n\n+44 (0) 207 776 1200\n\n\n\n\nJuliet Thompson/ Clare Terlouw\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFinancial Dynamics\n\n\n+44 (0) 207 831 3113\n\n\n\n\nBen Brewerton/ Susan Quigley\n\n\n\n\n\n\n\n\n\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END MSCLAMATMMITBBL\n ","length":4163,"tagName":"div"}]